Abstract: The present disclosure relates allose inducing programmed cell death in hormone refractory prostate cancer cell lines. More particularly, the present disclosure relates to a D-allose inducing programmed cell death in hormone refractory prostate cancer cell line of DU145 in dose-dependent manner by repressing cell growth and inhibiting cell cycle as well as by reducing expression of caspase-3 and poly (ADP-ribose) polymerase (PARP).
Type:
Application
Filed:
October 25, 2010
Publication date:
March 24, 2011
Applicant:
INDUSTRY-ACADEMIC COOPERATION FOUDATION, GYEONGSANG NATIONAL UNIVERSITY